Research paper| Volume 10, ISSUE 2, P118-129, September 1995

Purification of human blood eosinophils by a combination method using anti-CD16 monoclonal antibody, immunobeads, and Nycodenz density gradient

      This paper is only available as a PDF. To read, Please Download here.


      A simple method is described for the procurement of human blood eosinophil phenotypes by combining an anti-CD16 monoclonal antibody, immunobeads, and a non-toxic and non-ionic density gradient medium, Nycodenz. The purification depends on the removal of mononuclear cells using a 1.076/1.102 g/ml Nycodenz density gradient, partial removal of neutrophils based on different binding to plastic dishes, interaction of residual neutrophils with immunobeads via an anti-CD16 monoclonal antibody and, finally, extraction of eosinophil phenotypes by sifting the immunobeads-loaded neutrophils through an 1.080/1.102 g/ml Nycodenz density gradient. This method permits simultaneous preparation of highly purified normodense (>1.080 g/ml) and hypodense eosinophils (<1.080 g/ml) with reasonable chemiluminescence responses to opsonized zymosans and helminthotoxic activity to opsonized schistosomula corresponding to their own immunocytological properties.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Dermatological Science
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Vadas MA
        • David JR
        • Butterworth A
        • Pisani NT
        • Siongok TA
        A new method for the purification of human eosinophils and neutrophils and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni.
        J Immunol. 1979; 122: 1228-1236
        • Gärtner I
        Separation of human eosinophils in density gradients of polyvinylpyrrolidone coated silica gel (Percoll).
        Immunology. 1980; 40: 133-136
        • Yadanbakhsh M
        • Eckmann CM
        • Boer MD
        • Roos D
        Purification of eosinophils from normal human blood, preparation of eosinophoplasts and characterization of their response to various stimuli.
        Immunology. 1987; 60: 123-129
        • Hansel TT
        • Pound JD
        • Thompson RA
        Isolation of eosinophils from human blood.
        J Immunol Methods. 1990; 127: 153-164
        • Frick WE
        • Sedgwick JB
        • Busse WW
        Hypodense eosinophils in allergic rhinitis.
        J Allergy Clin Immunol. 1988; 82: 119-125
        • Kloprogge E
        • De Leeuw AJ
        • De Monchy JGR
        • Kauffman HF
        Hypodense eosinophilic granulocytes in normal individuals and patients with asthma: generation of hypodense cell populations in vitro.
        J Allergy Clin Immunol. 1989; 83: 393-400
        • Winqvist I
        • Oloffson T
        • Olsson I
        • Persson AM
        • Hallberg T
        Altered density, metabolism and surface receptors of eosinophils in eosinophilia.
        Immunology. 1982; 47: 531-539
        • Prin L
        • Capron M
        • Tonnel AB
        • Bletry O
        • Capron A
        Heterogeneity of human peripheral eosinophils: variability in cell density and cytotoxic ability in relation to the levels and the origin of hypereosinophilia.
        Arch Allergy Appl Immunol. 1983; 72: 336-346
        • Miyasato M
        • Iryo K
        • Kasada M
        • Tsuda S
        Varied density of eosinophils in patients with atopic dermatitis reflecting treatment with antiallergic drug.
        J Invest Dermatol. 1988; 90: 589
        • Nishida A
        • Kimura H
        • Nakano M
        • Goto T
        A sensitive and specific chemiluminescence method for estimating the ability of human granulocytes and monocytes to generate O2.
        Clin Chem Acta. 1989; 179: 177-182
        • Roos D
        • Bot AAM
        • Van Schaik MLJ
        • De Boer M
        • Daha MR
        Interaction between human neutrophils and zymosan particles: the role of opsonins and divalent cations.
        J Immunol. 1981; 126: 433-439
        • Ramalho-Pinto FJ
        • Gazzineli G
        • Howells RE
        • MotaSantos TA
        • Figueiredo EA
        • Pellegrino J
        Schistosoma mansoni: defined system for stepwise transformation of cercariae to schistosomula in vitro.
        Exp Parasitol. 1974; 36: 360-372
        • Miyasato M
        • Tsuda S
        • Kasada M
        • Iryo K
        • Sasai Y
        Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid.
        Arch Dermatol Res. 1989; 281: 304-309
        • Saito H
        • Yamada K
        • Breard J
        • Yoshie O
        • Mathe G
        A monoclonal antibody reactive with human eosinophils.
        Blood. 1986; 67: 50-56
        • Fleit HB
        • Wright SD
        • Unkeless JC
        Human neutrophil Fcγ receptor distribution and structure.
        in: 3rd ed. Proc Natl Acad Sci USA. 79. 1982: 3275-3279
        • Looney RJ
        • Ryan DH
        • Takahashi K
        • Fleit HB
        • Cohen HJ
        • Abraham GN
        • Anderson CL
        Identification of a second class of IgG Fc receptor on human neutrophils.
        J Exp Med. 1986; 163: 826-836
        • Graziano RF
        • Looney RJ
        • Shen L
        • Fanger MW
        FcγR- mediated killing by eosinophils.
        J Immunol. 1989; 142: 230-235
        • Kulczycki A
        Human neutrophils and eosinophils have structurally distinct Fcg receptors.
        J Immunol. 1984; 133: 849-854
        • Yadanbakhsh M
        • Eckmann CE
        • Roos D
        Characterization of the intetaction of the human eosinophils and neutrophils with opsonized particles.
        J Immunol. 1985; 135: 1378-1384
        • Hansel TT
        • Pound JD
        • Pilling D
        • Kitas GD
        • Salmon M
        • Gentle TA
        • Lee SS
        • Thompson RA
        Purification of human blood eosinophils by negative selection using immunomagnetic beads.
        J Immunol Methods. 1989; 122: 97-103
        • Hartnel A
        • Moqbel R
        • Walsh GM
        • Bradley B
        • Kay AB
        Fcγ and Math Eq receptor expression on normal density and low density human eosinophils.
        Immunology. 1990; 69: 264-270
        • Tai PC
        • Spry CJF
        Purification of normal human eosinophils using the differential binding capacities of blood leucocytes for complexed rabbit IgG.
        Clin Exp Immunol. 1977; 28: 256-260
        • Hansel TT
        • De Vries JM
        • Iff T
        • Rihs S
        • Wandilak M
        • Betz S
        • Blaser K
        • Walker C
        An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils.
        J Immunol Methods. 1991; 145: 105-110
        • Rickwood D
        • Ford T
        • Graham J
        A new nonionic iodinated gradient medium.
        Anal Biochem. 1982; 123: 23-32
        • Ford TC
        • Richwood D
        Formation of isotonic Nycodenz gradients for cell separation.
        Anal Biochem. 1982; 124: 293-298
        • Tsuda S
        • Miyasato M
        • Iryo K
        • Ichiki M
        • Kiyonaga H
        • Kasada M
        • Sasai Y
        Isolation of peritoneal eosinophils from polymyxin B-treated guinea pigs on density gradient of Nycoden, a new non-ionic iodinated gradient medium.
        Biomed Res. 1986; 7: 389-397
        • Bratting NW
        • Medina-De LA
        • Garza CE
        • Tischendorf FW
        Comparative study of eosinophil purification on Nycodenz, Metrizamide and Percoll density gradient.
        Eur J Haematol. 1987; 39: 148-153
        • Tai PC
        • Spry CJF
        • Peterson C
        • Venge P
        • Olsson I
        Monoclonal antibodies distinguish between storage and secreted forms of eosinophilic cationic protein.
        Nature. 1984; 309: 182-184
        • Miyasato M
        • Taguchi K
        • Tsuda S
        • Kitamura N
        • Kato K
        Eosinophil chemiliminescence response to cytokines and opsonized zymosans in atopic dermatitis.
        Int Arch Allergy Immunol. 1994; 104: 24-26